Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Unknown 4Recruiting 4Withdrawn 3Not yet recruiting 3Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Early-stage Peripheral Non-small Cell Lung Cancer 1

Interventions

Specimen Handling 7Educational Status 7Cisplatin 7Standard of Care 6Interviews as Topic 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Carboplatin 5Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Fluorouracil 4Drug Therapy 4lenvatinib 3camrelizumab 3Surveys and Questionnaires 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Lenalidomide 3Gemcitabine 3Fluorodeoxyglucose F18 3Exercise 3Early Intervention, Educational 3Dexamethasone 3Cytarabine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × OTHER × Drug Delivery Systems × Clear all
NCT07167459 2025-09-11

Personalized SBRT in Early-Stage Peripheral NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Enrolling by invitation
251 enrolled
Thoracic

Early-stage Peripheral Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡